bisoprolol has been researched along with Left Ventricular Outflow Obstruction in 6 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
Excerpt | Relevance | Reference |
---|---|---|
"Treatment with bisoprolol was well-tolerated and effective in relieving obstruction and improving symptoms in a significant proportion of patients with symptomatic obstructive HCM." | 1.72 | Bisoprolol for treatment of symptomatic patients with obstructive hypertrophic cardiomyopathy. The BASIC (bisoprolol AS therapy in hypertrophic cardiomyopathy) study. ( Caiazza, M; Calabrò, P; Cirillo, A; Dongiglio, F; Franco, F; Fusco, A; Limongelli, G; Lioncino, M; Mazzella, M; Monda, E; Moscarella, E; Pacileo, G; Palmiero, G; Rubino, M; Sepe, J; Verrillo, F, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Monda, E | 1 |
Lioncino, M | 1 |
Palmiero, G | 1 |
Franco, F | 1 |
Rubino, M | 1 |
Cirillo, A | 1 |
Verrillo, F | 1 |
Fusco, A | 1 |
Caiazza, M | 1 |
Mazzella, M | 1 |
Moscarella, E | 1 |
Dongiglio, F | 1 |
Sepe, J | 1 |
Pacileo, G | 1 |
Calabrò, P | 1 |
Limongelli, G | 1 |
Minami, Y | 1 |
Hagiwara, N | 1 |
Nistri, S | 1 |
Olivotto, I | 1 |
Maron, MS | 1 |
Ferrantini, C | 1 |
Coppini, R | 1 |
Grifoni, C | 1 |
Baldini, K | 1 |
Sgalambro, A | 1 |
Cecchi, F | 1 |
Maron, BJ | 1 |
Cabrera-Bueno, F | 1 |
García-Pinilla, JM | 1 |
Gómez-Doblas, JJ | 1 |
Montiel-Trujillo, A | 1 |
Rodríguez-Bailón, I | 1 |
de Teresa-Galván, E | 1 |
Watt, J | 1 |
Hogg, KJ | 1 |
Danton, M | 1 |
Kondo, I | 1 |
Mizushige, K | 1 |
Nozaki, S | 1 |
Iwado, Y | 1 |
Masugata, H | 1 |
Kohno, M | 1 |
Matsuo, H | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Effect of Metoprolol in Post Alcohol Septal Ablation Patients With Hypertrophic Cardiomyopathy[NCT04133532] | Phase 4 | 22 participants (Actual) | Interventional | 2020-03-05 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for bisoprolol and Left Ventricular Outflow Obstruction
Article | Year |
---|---|
Beta-blocker therapy for dynamic left ventricular outflow tract obstruction induced by exercise.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Bisoprolol; Cardiomyopathy, Hypertrophic; Echocardiogr | 2007 |
5 other studies available for bisoprolol and Left Ventricular Outflow Obstruction
Article | Year |
---|---|
Bisoprolol for treatment of symptomatic patients with obstructive hypertrophic cardiomyopathy. The BASIC (bisoprolol AS therapy in hypertrophic cardiomyopathy) study.
Topics: Adult; Bisoprolol; Cardiomyopathy, Hypertrophic; Disopyramide; Humans; Retrospective Studies; Ventri | 2022 |
Pharmacological Strategies for Midventricular Obstruction in Patients with Hypertrophic Cardiomyopathy.
Topics: Aneurysm; Bisoprolol; Cardiomyopathy, Hypertrophic; Humans; Ventricular Outflow Obstruction; Ventric | 2019 |
β Blockers for prevention of exercise-induced left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Bisoprolol; Cardiomyopathy, Hypertrophic; Cohort Studies; Confid | 2012 |
Resolution of dynamic left ventricular outflow tract obstruction caused by retained native leaflets following mitral valve replacement using medical treatment.
Topics: Aged; Bisoprolol; Cardiotonic Agents; Echocardiography; Female; Heart Valve Prosthesis; Heart Valve | 2006 |
Effect of cibenzoline, a class ia antiarrhythmic agent, on left ventricular diastolic function in hypertrophic cardiomyopathy.
Topics: Administration, Oral; Aged; Anti-Arrhythmia Agents; Bisoprolol; Blood Flow Velocity; Cardiomyopathy, | 2001 |